Cargando…

Medical Expenditures Associated With Hypertension in the U.S., 2000–2013

INTRODUCTION: Trends of prevalence, treatment, and control of hypertension have been documented in the U.S., but changes in medical expenditures associated with hypertension over time have not been evaluated. This study analyzed these expenditures during 2000–2013 among U.S. adults. METHODS: Data fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Donglan, Wang, Guijing, Zhang, Ping, Fang, Jing, Ayala, Carma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823517/
https://www.ncbi.nlm.nih.gov/pubmed/29153117
http://dx.doi.org/10.1016/j.amepre.2017.05.014
_version_ 1783301893673451520
author Zhang, Donglan
Wang, Guijing
Zhang, Ping
Fang, Jing
Ayala, Carma
author_facet Zhang, Donglan
Wang, Guijing
Zhang, Ping
Fang, Jing
Ayala, Carma
author_sort Zhang, Donglan
collection PubMed
description INTRODUCTION: Trends of prevalence, treatment, and control of hypertension have been documented in the U.S., but changes in medical expenditures associated with hypertension over time have not been evaluated. This study analyzed these expenditures during 2000–2013 among U.S. adults. METHODS: Data from the Medical Expenditure Panel Survey were analyzed in 2016. The study population was non-institutionalized men and non-pregnant women aged ≥18 years. Hypertension was defined as ever been diagnosed with hypertension or currently taking antihypertensive medications. Medical expenditures included all payments to medical care providers. Expenditures associated with hypertension were estimated by two-part regression models and adjusted into 2015 U.S. dollars. Controlling variables included sociodemographic characteristics, marital status, insurance, region, smoking status, weight status, health status, and comorbidities. Trends were analyzed using joinpoint method. RESULTS: Total per-person annual expenditures associated with hypertension in 2000–2001 ($1,399) were not significantly different from those in 2012–2013 ($1,494) (average annual percent change [AAPC]= −0.6%, p=0.794), but annual national spending increased significantly from $58.7 billion to $109.1 billion (AAPC=8.3%, p=0.015), mainly because of the increase in the number of people treated for hypertension. Per-person outpatient payments were 22.7% higher in 2012–2013 than in 2000–2001 ($416 vs $322, p<0.05; AAPC=0.8%, p-trend 0.826). Payments for prescription medications took up a larger proportion of the medical expenditures associated with hypertension, compared to payments for outpatient or other services (33%–46%). CONCLUSIONS: During 2000–2013, annual national medical expenditures associated with hypertension increased significantly. Preventing hypertension could alleviate hypertension-associated economic burden.
format Online
Article
Text
id pubmed-5823517
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-58235172018-02-22 Medical Expenditures Associated With Hypertension in the U.S., 2000–2013 Zhang, Donglan Wang, Guijing Zhang, Ping Fang, Jing Ayala, Carma Am J Prev Med Article INTRODUCTION: Trends of prevalence, treatment, and control of hypertension have been documented in the U.S., but changes in medical expenditures associated with hypertension over time have not been evaluated. This study analyzed these expenditures during 2000–2013 among U.S. adults. METHODS: Data from the Medical Expenditure Panel Survey were analyzed in 2016. The study population was non-institutionalized men and non-pregnant women aged ≥18 years. Hypertension was defined as ever been diagnosed with hypertension or currently taking antihypertensive medications. Medical expenditures included all payments to medical care providers. Expenditures associated with hypertension were estimated by two-part regression models and adjusted into 2015 U.S. dollars. Controlling variables included sociodemographic characteristics, marital status, insurance, region, smoking status, weight status, health status, and comorbidities. Trends were analyzed using joinpoint method. RESULTS: Total per-person annual expenditures associated with hypertension in 2000–2001 ($1,399) were not significantly different from those in 2012–2013 ($1,494) (average annual percent change [AAPC]= −0.6%, p=0.794), but annual national spending increased significantly from $58.7 billion to $109.1 billion (AAPC=8.3%, p=0.015), mainly because of the increase in the number of people treated for hypertension. Per-person outpatient payments were 22.7% higher in 2012–2013 than in 2000–2001 ($416 vs $322, p<0.05; AAPC=0.8%, p-trend 0.826). Payments for prescription medications took up a larger proportion of the medical expenditures associated with hypertension, compared to payments for outpatient or other services (33%–46%). CONCLUSIONS: During 2000–2013, annual national medical expenditures associated with hypertension increased significantly. Preventing hypertension could alleviate hypertension-associated economic burden. 2017-12 /pmc/articles/PMC5823517/ /pubmed/29153117 http://dx.doi.org/10.1016/j.amepre.2017.05.014 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Zhang, Donglan
Wang, Guijing
Zhang, Ping
Fang, Jing
Ayala, Carma
Medical Expenditures Associated With Hypertension in the U.S., 2000–2013
title Medical Expenditures Associated With Hypertension in the U.S., 2000–2013
title_full Medical Expenditures Associated With Hypertension in the U.S., 2000–2013
title_fullStr Medical Expenditures Associated With Hypertension in the U.S., 2000–2013
title_full_unstemmed Medical Expenditures Associated With Hypertension in the U.S., 2000–2013
title_short Medical Expenditures Associated With Hypertension in the U.S., 2000–2013
title_sort medical expenditures associated with hypertension in the u.s., 2000–2013
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823517/
https://www.ncbi.nlm.nih.gov/pubmed/29153117
http://dx.doi.org/10.1016/j.amepre.2017.05.014
work_keys_str_mv AT zhangdonglan medicalexpendituresassociatedwithhypertensionintheus20002013
AT wangguijing medicalexpendituresassociatedwithhypertensionintheus20002013
AT zhangping medicalexpendituresassociatedwithhypertensionintheus20002013
AT fangjing medicalexpendituresassociatedwithhypertensionintheus20002013
AT ayalacarma medicalexpendituresassociatedwithhypertensionintheus20002013